UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epithelial-to-mesenchymal transition of the mesothelial cell—its role in the response of the peritoneum to dialysis

Nephrology, dialysis, transplantation, 2006-07, Vol.21 (suppl-2), p.ii2-ii7

2006

Volltextzugriff (PDF)

EX VIVO ANALYSIS OF DIALYSIS EFFLUENT-DERIVED MESOTHELIAL CELLS AS AN APPROACH TO UNVEILING THE MECHANISM OF PERITONEAL MEMBRANE FAILURE

Peritoneal dialysis international, 2006-01, Vol.26 (1), p.26-34

2006

Volltextzugriff (PDF)

Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients : Pathologic significance and potential therapeutic interventions

Journal of the American Society of Nephrology, 2007-07, Vol.18 (7), p.2004-2013

2007

Volltextzugriff (PDF)

Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells

The New England journal of medicine, 2003-01, Vol.348 (5), p.403-413

2003

Volltextzugriff (PDF)

Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution

Peritoneal dialysis international, 2003-03, Vol.23 (2), p.138-145

2003

Volltextzugriff (PDF)

Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate and glucose-degradation products

Journal of leukocyte biology, 2003-04, Vol.73 (4), p.482-492

2003

Volltextzugriff (PDF)

Mesenchymal Conversion of Mesothelial Cells as a Mechanism Responsible for High Solute Transport Rate in Peritoneal Dialysis: Role of Vascular Endothelial Growth Factor

American journal of kidney diseases, 2005-11, Vol.46 (5), p.938-948

2005

Volltextzugriff (PDF)

PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage

Laboratory investigation, 2010-10, Vol.90 (10), p.1517-1532

2010

Volltextzugriff (PDF)

Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance

Nephrology, dialysis, transplantation, 2007-01, Vol.22 (1), p.218-223

2007

Volltextzugriff (PDF)

Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis

Virchows Archiv : an international journal of pathology, 2004-03, Vol.444 (3), p.247-256

2004

Volltextzugriff (PDF)

Helicobacter pylori infection: a new cause of anorexia in peritoneal dialysis patients

Peritoneal dialysis international, 2001-01, Vol.21 Suppl 3 (3_suppl), p.S152-156

2001

Volltextzugriff (PDF)

Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing

Peritoneal dialysis international, 2003-09, Vol.23 (5), p.450-455

2003

Volltextzugriff (PDF)

Thoughts on the start and withdrawal of dialysis

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013-11, Vol.33 (6), p.758

Sánchez-Tomero, José A

2013

Volltextzugriff (PDF)

Table showing dietary phosphorus/protein ratio for the Spanish population. Usefulness in chronic kidney disease

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Vol.33 (3), p.362

2013

Volltextzugriff (PDF)

Mast cell quantification in normal peritoneum and during peritoneal dialysis treatment

Archives of pathology & laboratory medicine (1976), 2006-08, Vol.130 (8), p.1188-1192

2006

Volltextzugriff (PDF)

Correction: Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis

Oncotarget, 2017-04, Vol.8 (14), p.24045-24045

2017

Volltextzugriff (PDF)

Managing ultrafiltration failure by peritoneal resting

Peritoneal dialysis international, 2000-11, Vol.20 (6), p.595-597

2000

Volltextzugriff (PDF)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis

Oncotarget, 2016-05, Vol.7 (21), p.30133-30146

2016

Volltextzugriff (PDF)

Prevalence of TT virus in serum and peripheral mononuclear cells from a CAPD population

Peritoneal dialysis international, 2000-01, Vol.20 (1), p.65-68

2000

Volltextzugriff (PDF)

Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo

Peritoneal dialysis international, 2000-11, Vol.20 (6), p.742-747

2000

Volltextzugriff (PDF)

Oral paricalcitol as antiproteinuric agent in chronic kidney disease

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Vol.33 (5), p.709-715

2013

Volltextzugriff (PDF)

Spontaneous VEGF production by cultured peritoneal mesothelial cells from patients on peritoneal dialysis

Peritoneal dialysis international, 2000-11, Vol.20 (6), p.798-801

2000

Volltextzugriff (PDF)

Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysis

Peritoneal dialysis international, 2000-11, Vol.20 (6), p.631-636

2000

Volltextzugriff (PDF)

Reflexiones sobre la entrada y la retirada de diálisis

Nefrología (Madrid), 2013, Vol.33 (6), p.758-763

Sánchez-Tomero, José A.

2013

Volltextzugriff (PDF)

Tablas de ratio fósforo/proteína de alimentos para población española. Utilidad en la enfermedad renal crónica

Nefrología (Madrid), 2013, Vol.33 (3), p.362-371

2013

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Humans
(53)
Life Sciences & Biomedicine
(50)
Urology & Nephrology
(47)
Female
(37)
Male
(34)
Middle Aged
(32)
Adult
(26)
Aged
(26)
Peritoneal Dialysis
(25)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(21)
Emergency And Intensive Care: Renal Failure. Dialysis Management
(21)
Intensive Care Medicine
(21)
Peritoneal Dialysis - Adverse Effects
(14)
Nephrology. Urinary Tract Diseases
(13)
Peritoneum - Pathology
(12)
Prospective Studies
(12)
Animals
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epithelial-to-mesenchymal transition of the mesothelial cell—its role in the response of the peritoneum to dialysis

EX VIVO ANALYSIS OF DIALYSIS EFFLUENT-DERIVED MESOTHELIAL CELLS AS AN APPROACH TO UNVEILING THE MECHANISM OF PERITONEAL MEMBRANE FAILURE

Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients : Pathologic significance and potential therapeutic interventions

Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells

Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution

Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate and glucose-degradation products

Mesenchymal Conversion of Mesothelial Cells as a Mechanism Responsible for High Solute Transport Rate in Peritoneal Dialysis: Role of Vascular Endothelial Growth Factor

PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage

Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance

Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis

Helicobacter pylori infection: a new cause of anorexia in peritoneal dialysis patients

Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing

Thoughts on the start and withdrawal of dialysis

Table showing dietary phosphorus/protein ratio for the Spanish population. Usefulness in chronic kidney disease

Mast cell quantification in normal peritoneum and during peritoneal dialysis treatment

Correction: Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis

Managing ultrafiltration failure by peritoneal resting

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis

Prevalence of TT virus in serum and peripheral mononuclear cells from a CAPD population

Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo

Oral paricalcitol as antiproteinuric agent in chronic kidney disease

Spontaneous VEGF production by cultured peritoneal mesothelial cells from patients on peritoneal dialysis

Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysis

Reflexiones sobre la entrada y la retirada de diálisis

Tablas de ratio fósforo/proteína de alimentos para población española. Utilidad en la enfermedad renal crónica

Suchergebnisse filtern